Blogs
Healthcare and Medtech Research Reports
Aug 31, 2026
Summary For decades, narcolepsy drugs only managed symptoms (stimulants, sodium oxybate, wake-promoters); none addressed the underlying biology. In 2026, orexin receptor agonists changed the game by directly replacing the missing orexin signal that causes narcolepsy type 1 (NT1). On August 5, 2026, the FDA a...
Read More...
Aug 08, 2025
Narcolepsy is a chronic neurological disorder that disrupts the brain’s ability to regulate sleep-wake cycles. Often misunderstood and underdiagnosed, it typically begins in adolescence but may remain unrecognized for years. The hallmark symptoms include Excessive Daytime Sleepiness (EDS), sudden muscle weakness, v...
Read More...
Intratumoral Cancer Therapy: A Potential Weapon To Fight the Battle Against Cancer
Aug 05, 2026
The Next Wave of Radioligand Therapies: 5 Candidates to Watch
Mar 20, 2026
Newsletter/Whitepaper